Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 125 of 5804
-
Can radiation replace surgery for cancer spread to lymph nodes?
Disease control OngoingThis randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast cancer previously treated with chemotherapy and surgery. Lymph node dissection may remove cancer cells…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Early liver transplant offers hope for severe alcoholic hepatitis patients
Disease control CompletedThe purpose of this study is to validate a strategy of identification of patients for early liver transplantation in severe alcoholic hepatitis. In this setting, short-term survival is very low (approx. 25% at 6 months) and a pilot study has suggested (mathurin et al. N Engl J Me…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Broader pneumonia shield: new vaccine tested in children
⭐️ VACCINE ⭐️ CompletedThis open-label, multicenter study is designed to evaluate the safety, tolerability and immunogenicity of 13-valent pneumococcal conjugate vaccine in healthy children aged more than 15 months up to less than 18 years.
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 23, 2026 00:00 UTC
-
New hope for breast cancer survivors: letrozole extends remission
Disease control CompletedRATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by reducing the production of estrogen. PURPOSE: This randomized phase III trial is studying letrozole to see how well it works in treating women with bre…
Phase: PHASE3 • Sponsor: NCIC Clinical Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for rare epilepsy: fenfluramine made available for dravet patients
Disease control APPROVED_FOR_MARKETINGThe purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Experimental drug targets smallpox and monkeypox after exposure
Disease control AVAILABLEThe purpose of this clinical protocol is to treat individuals with Tecovirimat after exposure to orthopox viruses.
Sponsor: U.S. Army Medical Research and Development Command • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Zapping the brain to preserve memory — a precision approach puts it to the test
Symptom relief Not yet recruitingThis project optimizes high-resolution tACS to improve memory in healthy older adults, advancing drug-free approaches for ADRD. We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.
Phase: NA • Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Menopause heart risk targeted by tailored exercise and diet programs
Prevention Not yet recruitingCardiovascular disease is the leading cause of death in women, yet risk is systematically underestimated and preventive interventions are often initiated too late. Women are disproportionately affected by obesity, diabetes, and smoking, but they also derive greater cardioprotecti…
Phase: NA • Sponsor: Ludwig Boltzmann Institute for Cardiovascular Research • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
Could a preventive ablation during flutter treatment ward off future heart trouble?
Disease control Not yet recruitingPulmonary vein isolation (PVI) via catheter ablation has been successfully employed for years to treat symptomatic atrial fibrillation (AF). Moreover, PVI has not been used as a prophylactic intervention even in groups known to be high-risk for the future development of AF. Preli…
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New radiation method may make stem cell transplants safer for older leukemia patients
Disease control Not yet recruitingThis phase II trial tests the effect of total marrow and lymphoid irradiation (TMLI) in combination with fludarabine and melphalan as conditioning regimen in older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome that has not responded to previous treatm…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
A pill that mimics the body's oxygen sensor may free MDS patients from frequent blood transfusions
Disease control Not yet recruitingThe study is designed to determine the efficacy and safety of roxadustat for the treatment of anemia due to very low, low, or intermediate risk MDS in participants with high transfusion burden (HTB).
Phase: PHASE3 • Sponsor: Kyntra Bio • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a simple 14-day heart monitor patch prevent strokes in at-risk seniors?
Prevention Not yet recruiting* The goal of the screening trial is to determine whether early screening for atrial fibrillation improves outcomes, including lowering the chance of death, hospitalization for stroke, blood clots, heart failure, heart attack, and severe bleeding reduces the risk of stroke or hea…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Supercharged immune cells take on tough T-Cell cancers
Disease control Not yet recruitingTo determine the safety and efficacy (1-year PFS) of iC9/CD5CAR/IL-15 NK cells as consolidation in patients with aggressive T-cell malignances in first remission.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Stomach-shrinking procedure may help control blood sugar and delay insulin in type 2 diabetes
Disease control Not yet recruitingThe goal of this clinical trial is to determine whether Endoscopic Sleeve Gastroplasty (ESG)-induced weight loss can improve glycemic outcomes and alter the trajectory toward insulin dependence in adults with obesity and inadequately controlled Type 2 Diabetes (T2D) despite guide…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Ear stimulation may tame both fibromyalgia pain and PTSD
Symptom relief Not yet recruitingFibromyalgia (FM) pain and PTSD are highly prevalent and comorbid with associated increased risk of negative physical and mental health outcomes, including higher risk for opioid use and suicide. This project is designed to determine the effects of a 4 week trial of a device for …
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New malaria vaccine candidate enters human trial in thailand
⭐️ VACCINE ⭐️ Not yet recruitingThis project is the third part of a 5-year research program entitled "Malaria Infection Studies in Thailand (MIST)" and known as MIST3. MIST3's primary objectives are to assess the safety of the PvRII/Matrix-M vaccine candidate in healthy adult Thai volunteers and to establish wh…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC
-
Can a TROP2-targeting drug shrink hard-to-treat small bowel cancer?
Disease control Not yet recruitingSmall bowel adenocarcinoma is a rare cancer with a poor prognosis. For patients with locally advanced or metastatic disease, the usual first treatment is chemotherapy with platinum-based combinations such as FOLFOX or CapeOX. However, once the cancer grows after this treatment or…
Phase: PHASE2 • Sponsor: National Cancer Center, Japan • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Glowing dye could reveal hidden cancer spread in testicular tumors
Disease control Not yet recruitingTesticular cancer is highly curable, but approximately 20-30% of patients with clinical stage I disease harbor occult retroperitoneal lymph node metastases that are not detected by conventional imaging. Current risk-adapted management may lead to overtreatment in some patients wh…
Phase: NA • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a clot-busting drug help stroke patients on blood thinners? new trial aims to find out.
Disease control Not yet recruitingThe study will randomize patients with acute ischemic stroke and Direct Oral AntiCoagulants (DOAC) ingestion within 48 hours from enrollment (but otherwise eligible for thrombolysis) to administration of intravenous tenecteplase vs. placebo (1:1). Participants will be enrolled a…
Phase: PHASE3 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Hormone blocker plus targeted drug shows promise against tough uterine cancer
Disease control Not yet recruitingThis phase II trial tests how well elacestrant with everolimus works for the treatment of estrogen receptor (ER) positive endometrial cancer that has come back after a period of improvement (recurrent), that may have spread from where it first started to nearby tissue, lymph node…
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC